Can AI replace medical writers? Experts say not immediately
Artificial intelligence (AI) is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but…
Features
IRA holds the scope to shape pharma’s research strategy, say experts
Magazine: Are European biopharma manufacturers ‘nearshoring’?
Big pharma faces headwinds in China as vaccine sales decline
Rising Sirturo resistance highlights urgent need for new TB therapies
European agencies catch up with speedier regulatory pathways for CGTs in the US
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
Are European biopharma manufacturers ‘nearshoring’?
